Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I

Annals of the Rheumatic Diseases

Volumn 55, Issue 9, 1996, Pages 632-637

  Takashima, Hiroyuki ^a   Eguchi, Katsumi ^a   Kawakami, Atsushi ^a   Kawabe, Yojiro ^a   Migita, Kiyoshi ^a   Sakai, Masahiro ^a   Origuchi, Tomoki ^a   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FETUS; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; INFLAMMATION; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0029792698     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.9.632     Document Type: Article

References (49)

1. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in humansera. Proc Natl Acad Sci USA 1981;78:6476-80.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-9.
3. Osame M, Usuki K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986;i:1031-2.
4. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Galender A. Antibodies to human T-lymphotropic virus type-I in patients tropical spastic pararesis. Lancet 1985;ii:407-10.
5. Nishioka K, Maruyama I, Sato K, Kitazima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989;i:441.
6. Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, et al. Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 1992;51:769-76.
7. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, et al. Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 1994;344: 1116-9.
8. Mochizuki M, Watanabe T, Yamaguchi K, Takasuki K, Yoshimura K, Shirao M, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992;83:236-9.
9. Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-I and polymyositis in Jamaica. Lancet 1989;ii:1184-7.
10. Vernant JC, Buisson G, Magdeleine J, De-Thore J, Jouannelle A, Neisson-Vernant C, Monplaisir N. T-lymphocytic alveolitis, tropical spastic paresis, and Sjögren's syndrome. Lancet 1988;i:177.
11. Iwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I, et al. Induction of inflammtory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991;253:1026-8.
12. Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice. Nature 1989;341:72-4.
13. Wano Y, Hattori T, Matsuoka M, Takatsuki K, Chua AO, Gubler U, et al. Interleukin 1 gene expression in adult T cell leukemia. J Clin Invest 1987;80:911-6.
14. Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, et al. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I-encoded p40x and T3/Ti complex triggering. Cell 1987;48:343-50.
15. Siekevitz M, Feinberg MD, Holbrook N, Wong-Staol F, Greene WC. Activation of interleukin 2 and interleukin-2 receptor(Tac) promotor expression by the transactivator(tat) gene product of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1987;84:5389-93.
16. Shimizu K, Hirano T, Ishibashi K, Nakano N, Taga T, Sugamura K, et al. Immortalization of BGDF(BCGFII)-and BCDF-producing T cells by human T cell leukemia virus(HTLV) and characterization of human BGDF(B-CGF II). J Immunol 1985;134:1728-33.
17. Villiger PM, Cronin MT, Amenomori T, Wachsman W, Lotz M. IL-6 production by human T lymphocytes expression in HTLV-I-infected but not in normal T cells. J Immunol 1991;146:550-9.
18. Lal RB, Rudolph D, Buckner C, Pardi D, Hooper WC. Infection with human T-lymphotropic viruses leads to constitutive expression of leukemia inhibitory factor and interleukin-6. Blood 1993;81:1827-32.
19. Yamashica I, Katamine S, Moriuchi R, Nakamura Y, Miyamoto T, Eguchi K, et al. Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type I tax protein. Blood 1994;84:1573-8.
20. Miyatake S, Seiki M, Malefijt RD, Heike T, Fujisawa J, Takebe Y, et al. Activation of T-cell derivedlymphokine genes in T cells and fibroblasts: effects of human T cell leukemia virus type I p40x protein and bovine papilloma virus encoded E2 protein. Nucleic Acid Res 1988; 16: 6547-66.
21. Sakai M, Eguchi K, Terada K, Nakashima M, Yamashita I, Ida H, et al. Infection of human synovial cells by human T cell lymphotropic virus type I: proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells. J Clin Invest 1993;92:1957-66.
22. Lindholm PF, Kashanchi F, Brady JN. Transcriptional regulation in the human retrovirus HTLV-I. Virology 1993;4:53-60.
23. Smith MR, Greene WC. Molecular biology of the type I human T-cell leukemia virus(HTLV-I) and adult T-cell leukemia. J Clin Invest 1991;87:761-6.
24. Kawakami A, Eguchi K, Ueki Y, Migita K, Ida H, Nakao H, et al. Effects of lobenzarit disodium on human endothelial cells: lobenzarit disodium inhibits proliferative response, HLA-DR antigen expression, and T cell adherence toward endothelial cells. Arthritis Rheum 1991;34:296-303.
25. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki K, Shiraishi Y, et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes human leukemic T cells. Nature 1981;294:770-1.
26. Grassmann RC, Dengler I, Müller-Fleckenstein B, Fleckenstein B, McGuire K, Dokhelar MC, et al. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I: X-region genes transduced by a herpesvirus saimiri vector. Proc Natl Acad Sci USA 1989;86:3351-5.
27. Eguchi K, Migita K, Nakashima M, Ida H, Terada K, Sakai M, et al. Fibroblast growth factors released by wounded endothelial cells stimulate proliferatione of synovial cells. J Rheumatol 1992;19:1925-32.
28. Tanaka Y, Koyanagi Y, Chosa T, Yamamoto N, Hinuma Y. Monoclonal antibody reactive with both p28 and p19 of adult T-cell leukemia virus-specific polypeptides. Jpn J Cancer Res 1983;74:327-30.
29. Frei K, Bodmer S, Schwerdel C, Fontana A. Astrocyte-derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages. J Immunol 1986;137: 3521-27.
30. Ho DD, Rota TR, Hirsch MS. Infection of human endothelial cells by human T-lymphotropic virus type I. Proc Natl Acad Sci USA 1984;81:7588-90.
31. Hoxie JA, Matthews DM, Cines DB. Infection of human endothelial cells by human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1984;81:7591-5.
32. Yoshikura H, Nishida J, Yoshida M, Kitamura Y, Takaku F, Ikeda S. Isolation of HTLV derived from Japanese adult T-cell leukemia patients in human diploid fibroblast strain IMR90 and the biological characters of the infected cells. Int J Cancer 1984;33:745-9.
33. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Maruyama I, Nosaka T, et al. Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene. J Clin Invest 1993;92:186-93.
34. Sawada M, Suzumura A, Kondo N, Marunouchi T. Induction of cytokines in glial cells by trans activator of human T-cell lymphotropic virus type I. FEBS Lett 1992;313: 47-50.
35. Hoffman PM, Dhib-Jalbut S, Mikovits JA, Robbins DS, Wolf AL, Bergey GK, et al. Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc Natl Acad Sci USA 1992;89:11784-8.
36. Hirayama M, Miyadai T, Yokochi T, Sato K, Kubota T, Iida M, et al. Infection of human T-lymphotropic virus type I to astrocytes in vitro with induction of the class II major histocompatibility complex. Neurosci Lett 1988;92:34-9.
37. Ali A, Patterson S, Cruickshank K, Rudge P, Dalgleish AG, Knight SC. Dendritic cells infected in vitro with human T cell leukemia/lymphoma virus type-1 (HTLV-I); enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin Exp Immunol 1993;94:32-7.
38. Koyanagi Y, Itoyama Y, Nakamura N, Takamatsu K, Kira J, Iwamasu T, et al. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 1993;196:25-33.
39. Tschachler E, Robert-Guroff M, Gallo RC, Reitz MS. Human T-lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro. Blood 1989;73: 194-201.
40. Smith MR, Greene WC. Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia. J Clin Invest 1991;87:761-6.
41. Kim S-J, Kehrl JH, Burton J, Tendler CL, Jeang KT, Danielpour D, et al. Transactivation of the transforming growth factor β1 (TGF-β1) gene by human T lymphotropic virus type I tax: a potential mechanism for the increased production of TGF-β1 in adult T cell leukemia. J Exp Med 1990;172:121-9.
42. Lal RB, Rudolph D, Buckner C, Pardi D, Hooper WC. Infection with human T-lymphotropic viruses leads to constitutive expression of leukemia inhibitory factor and IL-6. Blood 1993;81:1827-32.
43. Yamamoto N, Okada M, Koyanagi Y, Kannagi M, Hinuma Y. Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science 1982;217:737-9.
44. x protein activate the mouse granulocyte-macrophage colony-stimulating factor gene through a common DNA element. Mol Cell Biol 1988;8:5581-7.
45. Nimer SD, Gasson JC, Hu K, Smalberg I, Williams JL, Chen IS, et al. Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Oncogene 1989;4:671-6.
46. Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection(HAMTSP). J Neurol Sci 1990;96: 103-23.
47. Hara H, Monta M, Iwaki T, Hatae T, Itoyama Y, Kitamoto T, et al. Detection of human T lymphotropic virus type I(HTLV-I) proviral DNA and analysis of T cell receptor Vβ CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Exp Med 1994;180:831-9.
48. Ichinose K, Nakamura T, Kawakami A, Eguchi K, Nagasato K, Shibayama K, et al. Increased adherence of T cells to human endothelial cells in patients with human T-cell lymphotropic virus type I-associated myelopathy. Arch Neurol 1992;49:71-6.
49. Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989;337:471-3.